Global Venous Thromboembolism Devices Market :Venous thromboembolism is a disease caused by the clotting of blood in the blood vessel which leads to restriction of blood flow within the circulatory system. It is classified into pulmonary embolism and deep vein thrombosis. Deep vein thrombosis is mainly occurred due to clotting of blood in deep vein (commonly in the leg). The formed DVT clot breaks off and flows to lungs known as pulmonary embolism which is a severe complication of deep vein thrombosis (DVT). Venous thromboembolism commonly occurs in aged persons with more than 60 years. People with overweight, persons with thicker blood and persons suffering from autoimmune disorders such as (lupus, rheumatoid arthritis etc.) or cancer are at higher risk of venous thromboembolism. Venous thromboembolism can cause chronic complications, such as post-thrombotic syndrome (PTS) or chronic thromboembolic pulmonary hypertension (CTEPH). The symptoms associated with the venous thromboembolism include dilated blood veins in legs and chest, oedema, fever, tachycardia, and dyspnoea. Lower extremities are the most common site for DVT, but other locations affected include the mesenteric, upper extremities, pelvic veins, and cerebral veins.
A sample of this report is available upon request @
The venous thromboembolism devices market is growing at a significant CAGR due to increase in geriatric population. Rise in government expenditure, increasing incidence of venous thromboembolism, and high unmet needs of currently available treatment procedures are fuelling the venous thromboembolism devices market. For instance, in 2014 May, U.S. FDA issued post market surveillance study for inferior vena cava filters which provides information regarding implementation of the filters and risks of pulmonary thromboembolism. Furthermore, increase in surgical procedures such as hip and knee replacements that are risk factors for venous thromboembolism conditions. Growing patient awareness regarding venous thromboembolism conditions expected to boost the venous thromboembolism devices market over the forecast period. However, high cost of deep vein thrombosis treatment, difficult pathophysiology of the venous thromboembolism hinders the growth of venous thromboembolism devices market. Similarly, stringent regulatory approvals for the development of products are expected to dampen growth of venous thromboembolism devices market over the forecast period.
The venous thromboembolism devices market is segmented on the basis of product type, disease type, and end user
Based on type of device, venous thromboembolism devices market is segmented into the following
Based on disease type, the venous thromboembolism devices market is segmented into the following
Based on end-user, the venous thromboembolism devices market is segmented into the following
To view TOC of this report is available upon request @
Globally, venous thromboembolism devices market is expected to grow at expeditiously owing to increase in incidences of venous thromboembolism conditions. Several local and international players are actively involved in growth of venous thromboembolism devices market. The growth of venous thromboembolism devices market is increased due to rise in prevalence of venous thromboembolism (According to the International Society on Thrombosis and Haemostasis, Inc. (ISTH), approximately 10 Mn cases of venous thromboembolism occur annually). The most commonly adopted strategies by industry players include new product launches with technological innovations, new product approvals, acquisitions & mergers, agreements, and collaborations to capture significant venous thromboembolism Devices Market share.
Need more information about this report @
Geographically, venous thromboembolism devices market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa. North America anticipated to hold the largest share in the venous thromboembolism devices market owing to increase in the incidence (According to U.S. International Society on Thrombosis and Haemostasis, Inc. (ISTH) there are around 100,000 to 300,000 venous thromboembolism related deaths reported annually) and prevalence rate, rise in demand for advanced treatment, and increase in aging population in the North America region may hold the largest share. Moreover, high healthcare expenditure, high awareness regarding the disease and treatments, and increase in prevalence rate are expected to create demand in Europe region. Asia-Pacific is a key region for venous thromboembolism devices market due to increase in the government expenditure and healthcare infrastructure.
Some of the players in venous thromboembolism devices market are Fukuda Denshi Co., Ltd (Japan), Baxter International Inc. (U.S), Lidco Group Plc. (U.K), All Pro Corporation (China), Abbott Laboratories (U.S), Accellent, Inc.(U.S), Cardiva Medical, Inc.(U.S), Biosensors International Group, Ltd.(Singapore), 3M Healthcare (U.S), and others.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Vendor Neutral Archive & PACS Market: Vendor Neutral Archive (VNA) is the medical imaging technology where the documents, images, or any file related to the clinical information are stored in the standard form with a standard interface so that they are accessed in vendor-neutral manner by the other systems. VNA is the further step of picture archiving and communication system (PACS) where it also provides the data storage with convenient access but it is costlier and time-consuming process compared to VNA system due to the migration of data. The advantages with the Global vendor neutral archive (VNA) & PACS Market system include an exchange of the clinical information, transparency, and clarity of information with cost efficiency in less time.
Increase in the storage of clinical information, government initiatives for better healthcare, vendor flexibility & accessibility, reforms in healthcare information technology, technological advancements, and rise in the demand for disaster management and lifecycle management solutions are anticipated propel the Global Vendor Neutral Archive & PACS Market over the forecast period. However, insecurity in data storage, lack of harmonization in industry, complex technology, lack of skilled professionals, and high cost for initial investments might impede the growth of vendor neutral archive (VNA) & PACS market over the forecast period.
A sample of this report is available upon request @
Vendor neutral archive (VNA) market segmented based on mode of delivery, business mode, and vendor type
Based on the mode of delivery, vendor neutral archive (VNA) market segmented into the following
Based on the business mode, vendor neutral archive (VNA) market segmented into the following
Based on the vendor type, vendor neutral archive (VNA) market segmented into the following
Picture archiving and communication system (PACS) market segmented based on imaging technology, component type, business mode, and mode of delivery
Based on the imaging technology, picture archiving and communication system (PACS) market segmented into the following:
Based on the component, picture archiving and communication system (PACS) market segmented is segmented into the following:
Based on the business mode, picture archiving and communication system (PACS) market segmented is segmented into the following:
Based on the mode of delivery, picture archiving and communication system (PACS) market segmented is segmented into the following:
To view TOC of this report is available upon request @
Vendor neutral archive (VNA) & PACS market is in the growing stage owing to increase in the popularity of VNA solutions. Vendor neutral archive (VNA) & PACS market characterized by the inter-firm partnerships for delivering the compatible solutions to healthcare providers. Vendor neutral archive (VNA) & PACS market has a significant growth with the development of products enable integration of vendor neutral archives with electronic health records (EHRs). Acquisition and mergers, collaborations, and innovation of novel solutions are the strategies followed by the companies to increase their revenue. For instance, in January 2015, Lexmark International, Inc. acquired the Claron Technology, Inc. for developing the software. In addition, in January 2017, Carestream has collaborated with Ikazia hospital in Rotterdam about 5 years contract which may help to boost the company’s revenue.
Need more information about this report @
Geographically, vendor neutral archive (VNA) & PACS market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the vendor neutral archive (VNA) & PACS market owing to increase in the adoption of technology, innovation of new software for data storage, disaster recovery, and government initiations for promoting the healthcare sector in the region. In Europe, Germany, U.K., and France are dominating the vendor neutral archive (VNA) & PACS market owing to rise in demand for standard based storage, migration to PACS to VNA, and lifecycle management and disaster recovery. However, due to state wide and nation-wide healthcare reforms in Australia, Japan, and China and change in healthcare information technology policies Asia Pacific region has created significant oppurtunities for the players in the region.
Some of the players in vendor neutral archive (VNA) & PACS market are BridgeHead Software (U.K.), GE Healthcare (U.K.), McKesson Corporation (U.S.), Fujifilm Corporation (Japan), Agfa HealthCare (Belgium), Dell, Inc. (U.S.), Siemens Healthcare (Germany), Carestream Health (U.S.), and Merge Health (U.S.) to name a few.
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Immunization adjuvants are the substances added to the antibodies for improving the antibody capacity to secure against the disease. Immunization adjuvants enhance the immunogenicity of cleaned antigens, which has immunostimulatory abilities and has been utilized as a part of the antibodies for over 90 years. These days, a less number of antibody adjuvants are accessible, for example, MF 59 and aluminum salts. Immunizations are joined with the adjuvants to guarantee body creates an effective resistant reaction to secure the individual against the disease.
Increment in the pervasiveness of different zoonotic and different irresistible maladies, increment in the interest for enhanced inoculation against different sicknesses, government concentrate on sorting out the vaccination programs, an expansion in the utilization of engineered and recombinant antibodies foreseen to impel the immunization adjuvants advertise over the estimate time frame. Moreover, increment in the predominance of domesticated animals and partner creature illnesses, innovative headways in the aluminum hydroxide adjuvants, and government bolster for R&D exercises are foreseen to fuel the immunization adjuvants advertise over the conjecture time frame. In any case, stringent administrative arrangements, symptoms related with the adjuvants use, and high cost for the R&D exercises may obstruct the development of antibody adjuvants showcase over the estimate time frame.
A sample of this report is available upon request @
Vaccine adjuvants market is segmented on the basis of product type, vaccine type, route of administration, application, and end user
Based on the product type, vaccine adjuvants market is segmented into the following:
Based on the vaccine type, vaccine adjuvants market is segmented into the following:
Based on the route of administration, vaccine adjuvants market is segmented into the following:
Based on application, vaccine adjuvants market is segmented into the following:
Based on the end user, vaccine adjuvants market is segmented into the following:
To view TOC of this report is available upon request @
Vaccine adjuvants market is growing at a significant CAGR owing to increase in the prevalence of infectious diseases in humans, livestock & companion animals around the globe. Growing need for enhancing immune response and limited immunogenicity of novel vaccines expected to fuel the vaccine adjuvants market. Acquisitions and mergers, collaborations, and novel adjuvant introductions are the strategies applied by the market players to dominate the vaccine adjuvants market. For instance, in August 2013, FDA approved the Sequirus’s Afluria quadrivalent vaccine for people with 18 years or older. Similarly, funding by the government organizations to augment adjuvants research is anticipated to boost the vaccine adjuvants market. For instance, in April 2016, National Institute of Allergy and Infectious Diseases awarded 6 grants to various organizations including universities such as University of Wisconsin about US$ 3.1 Mn grants for vaccine adjuvants research.
Need more information about this report @
Geographically, vaccine adjuvants market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. North America is expected to hold a major share in vaccine adjuvants market owing to rise in the incidence of infectious diseases, government initiatives for organizing immunization programs, an increase in the collaborations for R&D activities on vaccine adjuvants are fuelling the market. For instance, in July 2016, U.S. Army Medical Research Institute of Infectious Diseases has collaborated with China’s Jilin Jian Yisheng Biopharma for the development of Ebola PIKA adjuvant vaccine. Europe holds a significant share in vaccine adjuvants market owing to rising in the prevalence of cancer, influenza, and other infectious diseases, increase the awareness about the vaccine adjuvant applications in the manufacturing of vaccines, and rise in the R&D activities are expected to propel the market growth. Asia Pacific vaccine adjuvants market is growing significantly due to rise in birth rate, increase in the prevalence of various infectious diseases, and development of newer adjuvants for improving the vaccine immunization.
Some of the players in vaccine adjuvants market are Invivogen (U.S.), MVP Laboratories, Inc. (U.S.), CSL Limited (Australia), SEPPIC (France), Brenntag Biosector (Denmark), Novavax, Inc. (U.S.), Agenus, Inc. (U.S.), OZ Biosciences (France), and Jilin Jian Yisheng Biopharma Co. Ltd. (China) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-vaccine-adjuvants-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Uveitis is the term that describes group of inflammatory diseases that affect eye and produces swelling. Uveitis can reduce sight and may cause vision loss. Causes of uveitis include infections such as brucellosis, leptospirosis, syphilis, tuberculosis, autoimmune diseases such as sarcoidosis, crohn’s disease, multiple sclerosis, arthritis, ankylosing spondylitis, and psoriatic arthritis. In addition, uveitis is also caused by drugs such as rifabutin and moxifloxacin. Uveitis affects uvea, lens, retina, optic nerve, and vitreous. Uveitis can be classified into anterior uveitis, intermediate uveitis, posterior uveitis and pan-uveitis based on part of inflammation.
The main driver for the growth of uveitis market is rise in prevalence and complications related to uveitis. In addition, increase in prevalence rates, market players betting heavily on research and development to develop new drugs, introduction of biologics into the market, fast approval of the drugs are fuelling the market growth of uveitis treatment market. According to the Ocular Immunology and Uveitis Foundation, worldwide 2,359,242 people are estimated to have the disorder. Even there are significant advances in research and therapeutics, prevalence of blindness secondary to uveitis has not been reduced in the past thirty years. However, few factors are restraining the growth of the market such as side effects of the drugs, eye irritation and lack of awareness about eye disorders in undeveloped regions, lack of sufficient healthcare infrastructure are hindering the uveitis treatment system market.
A sample of this report is available upon request @
Uveitis treatment market segmented based on drug class, disease type, by cause and distribution channel
Based on drug class, uveitis treatment market is segmented into
Based on disease type, uveitis treatment market is segmented into
Based on cause, uveitis treatment market is segmented into
Based on distribution channel, uveitis treatment market is segmented into
To view TOC of this report is available upon request @
Market players are developing novel molecules that can treat uveitis conditions in order to enhance their sales revenue. Companies are focusing on the development of the various drugs in the treatment of the uveitis. For instance, Aurinia Pharmaceuticals Inc. developing luveniq, a calcineurin inhibitor for the treatment of noninfectious uveitis. Recently it has completed its phase-II clinical trials. Similarly, other pipeline drugs such as EMEA, DE-109, Gevokizumab, Peptide B27PD are being developed by different companies. Considering the aforementioned factors global uveitis treatment market is expected to grow at significant rate during forecast period.
Need more information about this report @
Geographically uveitis treatment market segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is leading in uveitis treatment market due to various factors such as early approval of drugs compared to other regions, increased R&D investments by market players, and high prevalence of the uveitis are contributing growth of the market. In Europe region due to increased prevalence of diseases such as HIV, multiple sclerosis that are underlying causes of uveitis conditions. Japan, China, and India are expected to play important role in the revenue growth of the Asia-Pacific uveitis treatment market. China and India market growth is due to rapidly developing healthcare infrastructure, increased research and development expenditure and growing awareness about the eye related diseases. However, manufacturing of eye preparations required aseptic conditions and the manufacturing plant should be GMP certified. Hence the cost related to these preparations are very high that have direct implication on cost of the drugs.
Some of the players in uveitis treatment market include AbbVie Inc. (U.S.), Eyegate Pharmaceuticals Inc. (US), Valeant Pharmaceuticals (Bausch + Lomb) (Canada), Novartis AG (Switzerland), Alimera Sciences Inc. (U.S.) and Santen Pharmaceutical Co. Ltd (Japan) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-uveitis-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Ultra-Widefield Retinal Imaging Devices Market:By Device Type (Tabletop, Handheld, Portable ), By Application (Glaucoma, Diabetic retinopathy, Age – Related Macular Degeneration, Central Serous Retinopathy, Vitreous Traction, Pediatric, Point of Care,Others), By End User (Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Research Institutes),and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis2012 to 2016 and Forecast 2017 to 2024
Peripheral retina is frequently affected by various diseases and ultra widefield (UWF) imaging has become an essential tool for evaluation of peripheral retinal pathology. The wide angle and high resolution of this technology was recently developed and updated along with multimodal capabilities, such as fluroscein and indocyanine green angiography, pseudocolor fundud photographs, and autofluorescence images. Using this UWF technology, important clinical observations have been made in normal population and patients with certain eye diseases like diabetic retinopathy, retinal vascular occlusion, retinal detachment, age-related macular degeneration etc. Growing geriatric population around the world is the major factor that drives the growth of Ultra-Widefield Retinal Imaging Devices market globally. As per to WHO statistics, population above 65 years were 13% of the whole population in 2010 and it is expected to reach 53% by 2020. Furthermore, increase in the prevalence of chronic eye diseases such as glaucoma, diabetic retinopathy, etc. boosts the market growth of Ultra-Widefield Retinal Imaging Devices. Moreover, presence of favorable reimbursements, advancements in the technology, and increase in R&D investments also propels the Ultra-Widefield Retinal Imaging Devices market growth globally. On the other hand, lack of awareness, high installation costs, high cost of testing, and dearth of skilled professionals restrains the growth of Ultra-Widefield Retinal Imaging Devices market globally.
A sample of this report is available upon request @
Market Scope: Ultra-Widefield Retinal Imaging Devices Market
Ultra-Widefield Retinal Imaging Devices Marketis segmented on the basis of Type, Application, End user and Geographical regions
Based on the Type, Ultra-Widefield Retinal Imaging Devices Marketis segmented into the following:
Based on the Application,Ultra-Widefield Retinal Imaging Devices Marketis segmented into the following:
Based on the End User, Ultra-Widefield Retinal Imaging Devices Marketis segmented into the following:
To view TOC of this report is available upon request @
Regional Analysis: Ultra-Widefield Retinal Imaging Devices Market
Geographically, Ultra-Widefield Retinal Imaging Devices Marketis segmented into North America, Europe, Asia Pacific, Latin America, and theMiddle East and Africa regions.North America is the largest market for Ultra-Widefield Retinal Imaging Devices followed by Europe due to the high adoption of advancements in the technologies, increase in the complications such as diabetic retinopathy, skin cancers etc., well established healthcare infrastructure, favorable reimbursement policies, and rapid increase in the geriatric population. Asia Pacific and Latin American regions are also anticipated to show the significant growth rate during the forecast period owing to the increase in awareness among the people, huge population pool, rise in number of geriatric patients, presence of emerging economies such as Brazil, India, China, Japan etc., increase in chronic complications related to ophthalmologic disorders
Competition Assessment: Ultra-Widefield Retinal Imaging Devices Market
Key playersprofiled in the global Ultra-Widefield Retinal Imaging Devices Marketinclude:
Notable Market Developments: Ultra-Widefield Retinal Imaging Devices Market
Need more information about this report @
Key Features of the Report:
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Turf and Ornamental Grass Seeds Market :By Type of Grass (Turf Grass (Rye Grass, Blue Kentucky Grass, Zoysia Grass, Tall Fescue, Bermuda Grass), Ornamental Grass (Feather Reed Grass, Fountain Grass, Fibre Optic Grass, Ravenna Grass, Purple Millet), By Origin (Organic, Synthetic), By Application (Sports Ground, Lawns, Gardens, Parks, Nurseries, Landscapes, Others), and Geography –Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis2013 to 2016 and Forecast 2017 to 2024
Turf and Ornamental seeds used for the development of turfgrass covering the land aesthetically in surrounding venues such as playground, home, golf course, and sports ground among others. turf and ornamental crops are of various kinds such as grass, landscapes, horticulture plants, decorative plants etc. Increase in golf courses globally, growing awareness regarding quality and safety of turf and ornamental crops are the major factors to drive the Turf and Ornamental seeds market globally. Furthermore, increase in adoption of gardening and lawns, growing demand for the bio pesticides, inclination towards the scenic beauty, increase in tourism sector across the globe, growing initiations taken by the government in maintaining the decorating plants in the countries also propels the growth of Turf and Ornamental seeds market globally. However, high R&D costs, lack of awareness hampers the growth of the Turf and Ornamental seeds market
A sample of this report is available upon request @
Market Scope: Turf and Ornamental Grass Seeds Market
Turf and Ornamental Grass Seeds Market is segmented on the basis ofType of Grass, Origin and Geographical regions
Based on type of Grass, Turf and Ornamental Grass Seeds Market is segmented into the followingTurf Grass
Based on Origin, Turf and Ornamental Grass Seeds Market is segmented into the following
Based on Application, Turf and Ornamental Grass Seeds Market is segmented into the following
To view TOC of this report is available upon request @
Regional Analysis: Turf and Ornamental Grass Seeds Market
Geographically, Turf and Ornamental Grass Seeds Market is segmented into North America, Europe, Asia Pacific, Latin America, and theMiddle East and Africa regions.North America and Europe holds the largest share in the Turf and Ornamental Grass Seeds market as they are the matured regions because of love towards decorum, nature, beauty and sports like golf and football. US in North America, France and Spain in Europe hold the highest share in the regions. Asia Pacific and Latin America are the emerging markets for the Turf and Ornamental Grass Seeds and these regions are growing at a rapid rate owing to the increase I n tourism sector, growing adoption of rich sports like golf and football, increase in adoption of gardening and maintaining lawns, rise in awareness regarding the Turf and Ornamental Grass plants.
Competition Assessment: Turf and Ornamental Grass Seeds Market
Key playersprofiled in the global Turf and Ornamental Grass Seeds Market include:
Need more information about this report @
Key Features of the Report:
Get access to full summary @
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Global Ultrasound Devices Market :Ultrasound devices are medical imaging devices used to visualize internal organs of the body by the transmission of high-frequency sound waves into the patient body with the help of probe. These high-frequency sound waves reflected by body organs into the probe and are transmitted to a display and generate the image by using echoes. Clinically, ultrasound devices are used to visualize liver, heart, kidneys, blood vessels, human fetus, and other internal body organs. Ultrasound devices also used in sonography, which helps in therapeutic and diagnostic procedures. Ultrasound devices market is projected to grow with a signficant CAGR over the forecast period.
Increase in the prevalence of chronic diseases related to cardiovascular, neurological, diabetes, and cancer, the wide range of ultrasound device applications, technological advancements such as 3D and 4D, and rise in demand for minimally invasive or non-invasive diagnostic procedures are anticipated to fuel the ultrasound devices market. Moreover, a rise in public-private partnership investments, increase in a geriatric population affected by various diseases, and growing awareness of early disease diagnosis among healthcare professionals and patients are expected to boost the ultrasound devices market over the forecast period. However, stringent regulatory policies for medical devices approvals, insufficient reimbursement policies for diagnosis, a high cost of diagnostic procedures, lack of skilled professionals to perform diagnosis, and high risk of data storage are the major factors hindering the growth of ultrasound devices market.
A sample of this report is available upon request @
Ultrasound devises market is segmented based on the device type, application, technology, and end users
Based on device type, ultrasound devices market is segmented into the following:
Based on technology, ultrasound devices market is segmented into the following
Based on application, ultrasound devices market is segmented into the following:
Based on end user, ultrasound devices market is segmented into the following
To view TOC of this report is available upon request @
Ultrasound devises market is growing at a significant CAGR owing to the development of technologically advanced devices with 3D & 4D technology and rise in prevalence of chronic diseases such as cancer. Most of the companies are focusing on acquisitions and mergers for the diversification of business segment. For instance, in August 2014, Cura Healthcare entered into the ultrasound devices business by the acquisition of DE Healthcare. The wide ranges of applications for the ultrasound devices are also boosting the revenue growth of ultrasound devices market. Product approvals and launching of new products help in strengthening product portfolio. For instance, in May 2016, Signostics received FDA approval for ultrasound device Uscan used in the urological care.
Need more information about this report @
Geographically, ultrasound devices market is segmented into following regions Viz. North America, Europe, Latin America, Middle East & Africa, and Asia-Pacific. Europe holds a significant share in ultrasound devices market owing to increase in the prevalence of chronic diseases, high adoption technological advanced devices, an increase in healthcare expenditure. In North America region, due to increase in the prevalence of cancer and diabetes majorly in U.S., technological advancements of the ultrasound devices, rise in geriatric population, an increase in awareness about early disease diagnosis are expected to fuel the ultrasound devices market in the region. Moreover, Asia-Pacific expected to exhibit significant growth in the global market, which is attributed to the development of healthcare infrastructure, increase in geriatric population and development of medical tourism in Asia Pacific region.
Some of the players in ultrasound devices market are Esaote SpA (Italy), Hitachi, Ltd. (Japan), Mindray Medical International Ltd (China), Koninklijke Philips N.V. (Netherlands), Fujifilm Holdings Corporation (Japan), Analogic Corporation (U.S), Siemens Ltd. (Germany), Toshiba Corporation (Japan), InSightec Ltd. (Israel), Cura Healthcare (India), and General Electric Corporation (U.S.) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-ultrasound-devices-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Tumor Ablation Market :Tumour ablation is a minimally invasive surgical method which enables treats solid tumors in which special probes are used to freeze or burn cancers without the usual surgery. Tumour ablation method is guided by the help of CT scan, MRI Scan and ultrasound to locate and to position the needle probe into the tumor which requires a tiny hole of 3mm diameter to introduce the probe. When the probe is within cancer it is attached to a generator which burns and freezes cancer. Most common cancers that are treated by this method are lung cancers, renal cancer, and liver cancer.
Increasing in a number of cancer cases and rise in geriatric population are the major factors which are attributing for the growth of tumor ablation market. As per the WHO statistics, cancer accounts for 13% of deaths globally every year, moreover, 70% increase in cancer incidences is anticipated over the next couple of decades. The global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, increase in the number of hospitals, ablation and surgical centers, less procedural costs associated with radiofrequency ablation tumor and advanced technologies in ablation devices, improved healthcare expenditure, growing awareness, and increased government support are the few more factors which expected to boost the growth of tumor ablation market globally. However, stringent regulatory framework, prolonged time of approvals for product launching and cost containment measures are expected to hamper the growth of tumor ablation market.
A sample of this report is available upon request @
Tumour Ablation Market is segmented on basis of function, technology, application, end user and Geographical regions.
Based on the function, the global tumor ablation market is segmented
Based on the technology, The Global Tumor Ablation Market is segmented
Based on the application, the global tumor ablation market is segmented
Based on the end user, the global tumor ablation market is segmented
To view TOC of this report is available upon request @
Innovations in resources and technologies required in tumor ablation have provided an ample of opportunities for various pharma and electronics companies to work for the betterment of currently available technologies of tumor ablation. Innovations such as high intensity focussed ultrasound (HIFU), irreversible electroporation and image-guided procedures are rising demand for adaptation of tumor ablation. Moreover, increased focus on R&D investments, product developments, and launches, acquisitions, mergers, and collaborations are few strategies adopted by the players in the market. For exemplary, in 2016, Medtronic launchedBarrx360 express radiofrequency ablation balloon catheter to treat Barrett’s esophagus and in 2016 may, BTG Plc. has acquired Galil Medical, cryoablation systems, and needles manufacturer.
Need more information about this report @
Tumor Ablation Market is segmented into North America, Asia-Pacific, Europe, and the Middle East & Africa, Latin America. North America holds the largest share in tumor ablation market followed by Europe owing to the high incidence and prevalence of major cancers such as liver, kidney, lung and bone metastasis, increase in inclination towards minimally invasive procedures for treating cancer, the rise in government funds for cancer research. According to the reports of American Cancer Society, annual cancer incidences in U.S are 300.2 per 100,000 people and 296.6 cases per 100,000 people in Canada. Asia Pacific is anticipated to show significant growth during the foresee period owing to large population pool, growing economic developments in countries like China and India and improved healthcare infrastructure.
Some of the players in tumour ablation market are Boston Scientific Corporation (U.S.), Angiodynamics, Inc. (U.S.), BTG International Ltd (UK), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), EDAP TMS S.A. (France), Mermaid Medical, Inc. (Denmark), Neuwave Medical, Inc. (U.S.), Sonacare Medical, LLC (U.S.) and Mesonix, Inc. (U.S.).
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-tumor-ablation-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Transcatheter heart valves (THV) are used to replace the heart valves with a prosthetic valve for treatment of severe aortic stenosis and mitral regurgitation. These heart valve diseases can be congenital or acquired later in life due to age related life style changes and may be other underlying diseases. If these are not treated can cause heart failure, stroke, blood clots, or death due to sudden cardiac arrest.
According to WHO, by 2050, the world’s population aged 60 years and older is expected to total 2 billion, up from 900 million in 2015, who are more susceptible to the valve heart disease. The prime driver for the transcatheter heart valves (THV) market is rising demand for less invasive procedure for high-risk patients such as patients having multiple chronic diseases, growing prevalence of heart valve disorders. Moreover, increased incidences of heart diseases and technological advances in transcatheter heart valves (THV) driving the market. However, high costs of transcatheter heart valves, associated risks in implantation of transcatheter, slipping of valves, and misplacement of catheters are decreasing the acceptance in patients and affecting the market growth negatively.
A sample of this report is available upon request @
Transcatheter heart valve (THV) market segmented on the basis of product type, by approach, and end-user
By product type, transcatheter heart valve market segmented into
By surgical procedure type, transcatheter heart valve market segmented into
By end-user, transcatheter heart valve market segmented into
To view TOC of this report is available upon request @
Transcatheter heart valve (THV) market is anticipated to grow at significant CAGR over the forecast period. Market players are focusing on investments in R&D to develop and launch various new and technologically advanced devices for making heart valve procedures safer and more effective and strengthening their positions in market. For instance, transcatheter aortic valve replacement or trans catheter aortic valve implantation has become novel procedures for patients who are considered high risk for standard valve replacement therapy. Apart from this, companies also focusing on mergers and acquisitions to enhance their market share. For instance in 2016, Edwards Lifesciences Corporation agreed to acquire Valtech Cardio Ltd., for trans catheter repair of mitral and tricuspid valves.
Need more information about this report @
Geographically transcatheter heart valve market segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America market is dominating among all regions. Over five million people in U.S. are diagnosed with heart valve disease each year. Europe market for transcatheter heart valves expected to grow at significant rate due to technological advancements, increase in awareness and acceptance of novel replacement devices for cardiac disorders. Emerging economies of Asia-Pacific region such as China and India expected to show significant growth in the market due to medical tourism, increasing patients with heart diseases and significant changing in lifestyle.
Some of the players in trans catheter market include Edwards Lifesciences Corporation (U.S.), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), and Medtronic (U.S) to name a few
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-transcatheter-heart-valve-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Therapeutic vaccines are biological combinations which develop immunity against a diseased tissue or cell. Therapeutic vaccines are administered to the patient in order to induce a defence mechanism against particular disease. These are developed to treat various cancer diseases, HIV, and Alzheimer’s disease etc. Prophylactic vaccines differ from therapeutic vaccines are used for the prevention and control of diseases, while the prophylactic vaccines are only used for prevention of diseases. Therapeutic vaccines are specially manufactured for the HIV positive individuals with the healthy immune system, to increase the ability to fight against microorganisms. Therapeutic vaccines are currently developed for chronic viral infections, such as human immunodeficiency virus (HIV), human papillomavirus (HPV), herpes simplex virus (HSV), cancer, hepatitis B virus, and hepatitis C virus etc. as an alternative to antiviral treatment.
Global Market Outline: Therapeutic Vaccines Market
The global therapeutic vaccines market is expected to grow at a significant CAGR due to increase in the prevalence of chronic diseases such as cancer, and HIV etc. According to World Health Organisation, an escalation of the diseases such as cancer (approximately 8.8 Mn people died in 2015) and HIV expected to drive the growth of global therapeutic vaccines market over the forecasting period. The advanced and active R&D activities for therapeutic vaccines by pharmaceutical companies for various types of cancers are in pipeline which is expected to create potential opportunity in the global therapeutic vaccines market in future. Apart from this, rising number of mergers and acquisitions, and an increase in funding from government for development of therapeutic vaccines might fuel the growth of global therapeutic vaccines market over the forecasting period. However, inefficient research and development and non-existent reimbursement policies for vaccines are the primary factors which are expected to hinder the growth of global therapeutic vaccines market. Similarly, stringent regulatory implications, higher cost of vaccines, lesser accessibility to the vaccines, availability of alternative treatments for the diseases, and some adverse effects associated with the vaccines might hamper the growth of global therapeutic vaccines market over the forecast period.
A sample of this report is available upon request @
Global therapeutic vaccines market has been segmented on the basis of product type, application, technologies, market type, and end user
Based on product type, global therapeutic vaccines market has been segmented into the following:
Based on application, global therapeutic vaccines market has been segmented into the following:
Based on technology, global therapeutic vaccines market has been segmented into the following:
Based on the valency, global therapeutic vaccines market has been segmented into the following:
Based on the end-user, global therapeutic vaccines market has been segmented into the following:
To view TOC of this report is available upon request @
The global therapeutic vaccines market is in the nascent stage where many players are actively involved in the development of therapeutic vaccines. Few companies have adopted some key business strategies, such as product innovation, and new product launching to ensure their dominance in the global therapeutic vaccines market. The global therapeutic vaccines market is positively affected by the significant rise in prevalence of chronic diseases such as cancer, and HIV etc. Few companies have taken an active lead in research and development of therapeutic vaccines. For instance, in April 2010, Dendreon Corporation, launched FDA approved immunotherapy drug Provenge, for the treatment of prostate cancer. According to U.S. Department of Health and Human Services, there are some vaccines in the clinical trial stage, such as Lucanix (Belagenpumatucel-L), gp100 melanoma vaccine, for Non-small cell lung cancer. Similarly, Merck & Co., Inc. and GSK Plc. are expected to launch vaccines such as GSK1572932A, and GV1001 having entered phase 3 trials.
Need more information about this report @
Geographically, the global therapeutic vaccines market has been segmented into following regions Viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share in global therapeutic vaccines market followed by Europe and Asia-Pacific. In North-America, U.S. contributes the largest share in global therapeutic vaccines market (according to U.S. Centres for Disease Control and Prevention (CDC), therapeutic vaccines can suppress almost 10 infectious diseases in U.S. by up to 90%). Rising technology support for the development of new vaccines and well-developed healthcare infrastructure expected to fuel the growth of therapeutic vaccines market in North-America region. Europe, which currently stands at the second position in global therapeutic vaccines market, and is expected to show a significant growth due to the increase in the number of patients with chronic diseases. Asia-Pacific region expected to grow at a significant rate due to rising prevalence of various infectious and chronic diseases and aging population. Large investments in the field of research and development and increasing medical tourism in Asian countries might fuel the growth of therapeutic vaccine market in the Asia-pacific region. Latin America is another important regional market, which offers vast opportunities for the players entering into this market, and is expected to grow moderately due to the high cost of therapeutic vaccines.
Some of the players in global therapeutic vaccines market are Merck & Co., Inc. (U.S.), GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Sanofi-Pasteur (France), Dendreon (U.S.). Agenus Inc. (U.S.), Valeant (Canada), Bavarian Nordic (Denmark), Pfizer, Inc. (U.S.) and Inovio Pharmaceuticals, Inc. (U.S.), to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-vaccines-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Therapeutic Drug Monitoring Market: By Product (Equipment (Proteomics Equipment, Immuno Assay Analysers and Others) and Consumables), By Drug class (Antibiotics, Immunosuppressant’s, Anti-Epileptic Drugs, Psychoactive Drugs, Anti-Arrhythmic Drugs and Others), By end user (Hospitals, Clinical Laboratories and Others) By Geography – Therapeutic Drug Monitoring Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Market Outline: Global Therapeutic Drug Monitoring Market
Therapeutic drug monitoring refers to the monitoring of drug concentrations in the body fluids, usually plasma, during the treatment or diagnosis of the condition or disease. The therapeutic drug monitoring is done for the specific drugs only because many drugs are not clearly related to their effects. The therapeutic drug monitoring aims to reduce the toxicity assisted with diagnosis or helps to enhance the drug efficiency. Some of the drugs have narrow therapeutic window. If the concentration is above the upper limit, it shows toxic effects. If the drug is below the lower level, it will not show therapeutic effect. Especially, for these type of drugs, therapeutic drug monitoring is used. Therapeutic drug monitoring helps the physicians to optimise the drug for getting the therapeutic outcome.
Market dynamics: Global Therapeutic Drug Monitoring Market
Global therapeutic drug monitoring is mainly driven by the rise in demand for the administration of personalized dosage of the medicine and technological advancements in tests that are used to monitor the drug therapeutics. In addition, prevalence of the psychiatric diseases and cancer which need the drug monitoring for the optimum therapeutic outcomes and advantages such as dose optimisation and applications in personalized medicine expected to boost the therapeutic drug monitoring market over the forecast period. Furthermore, advent of biomarker identification for cancer diagnostics expected to benefit the growth of global therapeutic drug monitoring market. However, high costs and lack of skilled professionals may hamper the global therapeutic drug monitoring market over coming years.
A sample of this report is available upon request @
Market Scope: Global Therapeutic Drug Monitoring Market
Global Therapeutic Drug Monitoring market is segmented based on products, drug class, and end user
Based on product, global therapeutic drug monitoring market is segmented into
Based on drug class, global therapeutic drug monitoring market is segmented into
Based on end user, global therapeutic drug monitoring market is segmented into
To view TOC of this report is available upon request @
Market Summary: Global Therapeutic Drug Monitoring Market
Global therapeutic drug monitoring devices market expected to grow at significant rates owing to the rise in prevalence of neuronal disorders and cancers worldwide. According to World Health Organization (WHO), about 50 Mn people have epilepsy worldwide and 80% of people from low and middle-income countries. Companies operating in global therapeutic monitoring market are developing new innovative products and gaining the competitive advantage. For instance, in September 2012, Bruker Corporation launched Toxtyper, an automated clinical spectroscopy solution for toxicology laboratories in Europe. Toxtyper is faster and reliable solution for the toxics and abusive drug monitoring. Furthermore, companies are adopting the merger and acquisition strategies to strengthen its product portfolio and increase their market position.
Regional Analysis: Global Therapeutic Drug Monitoring Market
Geographically therapeutic drug monitoring market is divided into five key regions, i.e. North America, Europe, Asia- Pacific, Latin America, and The Middle East & Africa. North America expected to have the major market share in global therapeutic drug monitoring owing to the rise in demand for metabolomics studies and high rate of organ transplantation. In addition, growth in the pharmacodynamics and kinetic studies for the dosage optimisation and growth in demand for the personalized medicine expected to boost the North America therapeutic drug monitoring market over the forecast period. Asia Pacific is expected to have the rapid growth rate owing to developing healthcare infrastructure, rise in R&D investments. Europe therapeutic drug monitoring market expected to have notable growth rate over the coming years due to rise in demand for personalized medicine and presence of key market players in the region.
Competition Assessment: Global Therapeutic Drug Monitoring Market
Key player’s profiles in global therapeutic drug monitoring market include
Notable Market Developments: Global Therapeutic Drug Monitoring Market
Need more information about this report @
Key Features of the Report:
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-therapeutic-drug-monitoring-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Tardive Dyskinesia Treatment Market :Tardive dyskinesia is a movement disorder which develops with long duration compliance to antipsychotic drugs. This is characterised primarily by random movements of tongue, jaws, lips and different muscles sometimes even with fingers, toes and legs. In sever conditions of tardive dyskinesia patients may experience heaving breathing associated with trunk or hips or muscles swaying movements. It is a long-term cause of neuroleptic drugs which are more often prescribed for certain mental, neurological or GI disorders.
Growing prevalence of patients suffering from various neurological disorders is the major factor driving the market growth of TD treatment. For example, In 2017 April, Neurocrine Biosciences has published a report which stated that about 5lakhs people are suffering from TD in U.S. Tardive dyskinesia treatment market is anticipated to grow significantly during the forecast period owing to rise in geriatric population, busy and tense lifestyle, growing prescription of anti-psychotic drugs etc. The factors which are hampering the growth TD market is approval process of new treatment approaches by respective governments, delayed diagnosis of the disease and lack of awareness regarding the disease.
A sample of this report is available upon request @
The tardive dyskinesia treatment market is classified on the basis of drug class, infection type distribution channel, and geography.
Based on drug class, the tardive dyskinesia treatment market is segmented into the following
Based on route of administration, the tardive dyskinesia treatment market is segmented into the following
Based on distribution channel, the tardive dyskinesia treatment market is segmented into the following
To view TOC of this report is available upon request @
A variety of medicines are used to treat tardive dyskinesia such as clonidine etc. Botox injections can be given for minor TD. Vitamin B6, vitamin E and branched chain amino acids are helpful in minimizing the symptoms of tardive dyskinesia. Benzodiazepines therapy is the most effective therapy for tardive dyskinesia. However, the development of tolerance is restraining its growth in the market. Teva’s AUSTEDO was approved for the treatment of chorea associated with tardive dyskinesia. Austedo is likely to create competition for INGREZZA of Neurocrine Biosciences.
Need more information about this report @
On the basis of Geographical regions, Global tardive dyskinesia treatment market is classified as into five key regions as Europe, Asia- Pacific, North America, Middle East & Africa and Latin America. North America is the dominating market in tardive dyskinesia owing to the development of new drugs, growing prevalence of tardive dyskinesia, rising investments on R&D investments. Europe and Asia Pacific are also expected to have significant growth rate due to the growing investments, rising awareness and rise in disposable income of the emerging countries.
Some of the players in global tardive dyskinesia treatment market are Biogen (U.S), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline Plc.(U.K), Johnson & Johnson Services, Inc.(U.S), Pfizer Inc.(U.S), Neurocrine Biosciences, Inc.(U.S), Novartis AG(Switzerland), AstraZeneca (U.K), Bayer AG (Germany) and Sanofi (France).
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-tardive-dyskinesia-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.
Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Surgical Devices Market: Surgical devices refer to the medical devices used to cutting, dilating, grasping, holding, and fulgurate the body tissues during the surgical procedures. Some surgical devices are designed for general use in surgery, while others are designed for a specific procedure or surgery. Surgical devices are used for various surgical procedures such as reconstructive and plastic surgeries and wound closures. These are commonly used in various therapeutic areas such as urology, neurology, cardiovascular medicine, orthopaedics, obstetrics, and gynaecology, etc. Over time, many different kinds of surgical instruments and tools have been invented. Due to technological advancements majority of the surgical devices has computerized. The surgical devices categorized into different tools like powered devices, mechanical cutters, graspers, retractors, distractors, tubes and suction tips, measurement tools, specula or dilators, tyndallers and among others
Global Market Outline: Surgical Devices Market
The global surgical devices market is expected to grow at a significant CAGR due to increase in the global population, and rise in the prevalence of various chronic diseases such as cancer, diabetes etc. Rise in demand for surgical tools due to increase in surgical procedures, increase in healthcare expenditure, increase in demand for plastic and reconstructive surgery, and rise in technological development leading to product innovations are the major factors fuel the growth of surgical devices market over the forecast period. Moreover, the favourable government policies for the manufacturing of surgical devices, the presence of numerous risk factors, such as hypertension, smoking, obesity, and diabetes, has led to the high prevalence of cardiovascular diseases and using of robotic systems might fuel the global surgical devices market over the forecast period. However, stringent government regulations, price competition in the industry and lack of proper reimbursement for surgical equipment may hamper the surgical devices market growth over the forecast period. Similarly, a rise in preference for advanced wound closure materials like fibrin sealants, implementation of acts like Patient Protection and Affordable Care Act (PPACA) in U.S., and Side effects with the products that lead to product recalls might hinder the growth of global surgical devices market.
A sample of this report is available upon request @
Surgical devices market segmented on the basis of product type, application, and end user
Based on product-type surgical devices market has been segmented into the following:
Based on the application surgical devices market has been segmented into the following:
Based on end-user surgical devices market has been segmented into the following:
To view TOC of this report is available upon request @
Geographically, surgical devices market is in a flourishing stage with several local, and international players operating in the surgical devices market. Increase in the prevalence of chronic diseases such as neurological disorders (according to World Federation of Neurology statistics, 12 in every 100 patients die due to neurological disorders), and rise in the number of road accidents (according to Association for Safe International Road Travel, nearly 2.35 million people are injured every year due to road accidents) has led to the increase in the demand for surgical devices. Launching of new products is the popular strategy followed by various medical devices companies in the global surgical equipment market, which has helped the manufacturers to gain substantial market share. For instance, in October 2013, Zimmer had launched three products for minimally invasive surgery, namely Viewline Retractor System, Tube Retraction System and Posterior Instrument Set which are used in microdiscectomy procedures. Similarly, innovation of modern technologies like minimally invasive surgery instruments, and robotic and power assisted equipment are the key factors fueling the growth of surgical devices market. For instance, in 2011, Intuitive Surgical, Inc., has developed the da Vinci Surgical System provided a breakthrough platform for the robotic-assisted surgeries.
Need more information about this report @
Geographically, the surgical devices market has been segmented into following regions Viz. North America, Asia-Pacific, Europe, Middle East & Africa, and Latin America. North America dominates the surgical devices market owing to rise in a number aging population, increase in the prevalence of chronic diseases in U.S. such as cancer, neurological disorders, and diabetes etc. The innovation of novel technologies and reimbursement scenario might boost the surgical devices market in North America. However, Europe holds a significant share in surgical devices market owing to the favourable regulatory framework, change in lifestyle, and increase in disposable income among consumers. Moreover, Asia-pacific surgical devices market is expected to substantial growth over forecasting period owing to increase in the medical tourism in Asian countries, rise in unmet healthcare needs, growing healthcare infrastructure in Asia Pacific region.
Some of the players in surgical devices market are Medtronic (U.S.), Stryker Corporation (U.S.), Johnson & Johnson Services Inc., (U.S.), NuVasive, Inc. (U.S.), Conmed Corporation (U.S.), Alcon company (a division of Novartis) (Switzerland.), Smith & Nephew (U.K.) , Zimmer Inc. (U.S.), Boston Scientific Corporation (U.S.), B. Braun Melsungen AG (Germany), KLS Martin Group (U.S.), and Integra LifeSciences Corporation (U.S.) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-surgical-devices-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Global Sterile Injectables Market: By Molecule Type (Large Molecules, Small Molecules), Drug Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Vaccines, Immunoglobulins, Peptide Antibiotics, and Others), Disease Indication (Cancer, Diabetes, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Route of Administration (Intravenous (IV), Intramuscular (IM), Subcutaneous (SC), and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Sterile Injectables Market Report Description:
Sterile Injectables market report gives a comprehensive outlook on sterile injectable across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on the sterile injectable market gives historical, current, and future market sizes (US$ Mn) of drug molecules, drug types, disease application, route of administration, end users, and geographic regions. This report studies sterile injectable market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the sterile injectable market report includes drug pipeline analysis, regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analysed sterile injectable market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the sterile injectable market report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply of sterile injectables.
A sample of this report is available upon request @
Sterile Injectables Market:
The sterile injectable market estimated to be valued US$ 361 Bn in 2016 and poised to grow at CAGR 7.3%. The market for sterile injectable projected to reach US$ 552 Bn by 2023.
Do the burgeoning product pipelines and drug patent expiries have a positive impact on the market?
The rising shift of pharmaceutical and biotechnology firms towards the development of medications for chronic diseases such as cancer, diabetes, and cardiovascular and among others have created ample growth opportunities for players in the market. Moreover, biologic have become a larger part of product pipelines of several drug developers, which could affect market growth positively over the forecast period. For instance, there are around 2,500 injectable products are in the developmental stage. Moreover, rising product patent expiries of several blockbusters in recent times expected to propel market growth over the forecast period. For instance, in 2015, Teva Pharmaceutical Industries Ltd. lost the patent for its top-selling multiple sclerosis drug Copaxone.
How operational and installation cost effects the sterile injectable market?
Several industry experts noted that the cost of establishing sterile injectable plants is significantly higher viz-a-viz non-sterile manufacturing plants owing to stringent aseptic requirements and complex manufacturing process; this has led to the consolidation of the industry by backward and forward integration. Moreover, competition from low-cost manufacturers, value chain integration coupled with high entry barrier for new players in the sterile injectable market expect impact market growth negatively over the forecast period.
North America accounts for larger market revenue share in global sterile injectable market
North America leads the global sterile injectable market in terms of revenue in 2016. Regions such as Asia Pacific and Europe presented better growth opportunities for the market players owing to conducive business policies and increased local production generic injectable. For instance, in 2013, Mylan Inc. completed the acquisition of the Agila injectables businesses from Strides Arcolab Limited.
To view TOC of this report is available upon request @
Competition Assessment
Key players profiled in the global sterile injectable market include:
Market players are focusing on mergers and acquisitions to improve their market position in sterile injectable market. For instance, in 2016, Baxter International Inc. acquired Claris Injectables Limited, a wholly owned subsidiary of Claris Lifesciences Limited, for total consideration of approximately $625mn. In 2015 Pfizer Inc. acquired Hospira, Inc., world’s leading provider of injectable and infusion technologies.
Key Findings of the Report:
Need more information about this report @
Key Features of the Report:
Detailed Segmentation
By Molecule Type
Drug Type
Disease Indication
Route of Administration
Distribution Channel
Geography
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-sterile-injectables-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Stem cell therapy market: Stem cell therapy involves use of stem cells to treat various diseases or disorders. Stem cells are fundamental for every tissue and organ in the body. Stem cells are indistinguishable biological cells that are able to differentiate into specialised cells (liver cells, cardiac cells etc.) and can renew itself (through mitosis) to produce more stem cells. Stem cells have the ability to replicate, repair, and replace other damaged tissues in the human body. In addition, stem cell based therapies are also used to treat several chronic diseases such as blood disorders, cancer and others.
Global Market Outline: Stem Cell Therapy Market
Growing awareness about the potency of stem cells in disease management, development of advanced gene based analysis techniques and increase in public, private investments in stem cell research are acting as growth drivers for stem cell therapy market. In addition, identification of new stem cell lines and development of infrastructure for stem cell banking & processing are propelling the growth of the global stem cell therapy market. However, ethical issues involved in stem cells research such as destruction of human embryos, religious beliefs are considered as road blocks for adaptation of stem cell therapy by patients. However, stringent regulations to conduct trials on humans, high-cost of research and storage of stem cells are some restraining factors for stem cell therapy market.
A sample of this report is available upon request @
Stem cell therapy market has been segmented on the basis of treatment mode, cell types, application, technology, and end-user
Based on treatment, stem cell therapy market is segmented into
Based on cell type, stem cell therapy market is segmented into
Based on technology, stem cell therapy market is segmented into
Based on end-user, stem cell therapy market segmented into
To view TOC of this report is available upon request @
Stakeholders in stem cell therapy such as academic institutions and research firms are collaborating in development of stem cell therapy and industry collaborations also projecting enormous growth of stem cell therapy market. For instance, in November 2015, Cellular Dynamics International, Inc. (FUJIFILM) collaborated with Roche to supply iCell (CDI’s induced pluripotent stem cell derived) products that enables in identification of novel drug candidates at the early stages of drug discovery. Similarly, in May 2017, Magenta Therapeutics, entered into strategic partnership with Be The Match BioTherapies, to improve and expand the use of curative stem cell transplantation.
Need more information about this report @
Geographically stem cell therapy market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Among the regions, North America dominates global stem cell therapy market due to factors such as increasing prevalence of chronic diseases, growing awareness, and rising investment in research and development activities. In Asia Pacific region, due to the favourable government policies, development healthcare infrastructure, industry collaborations in research and developments expected to boost stem cell therapy market. For instance, in April 2017, Plasticell, a developer of stem cell technologies and cell-based therapies, has announced that it has signed agreements with the Agency for Science, Technology and Research (A*STAR), Singapore, and the Nanyang Technological University (NTU), Singapore, to progress its therapeutic stem cell pipeline.
Some of the players in stem cell therapy market are Cytori Therapeutics Inc. (U.S.), Fibrocell Science (U.S.), Cellartis AB (Cellectis) (France), BioTime, Inc. (U.S.), GE Healthcare (U.S.), Thermo Fisher Scientific (U.S.), STEMCELL Technologies Inc. (Canada), Fujifilm Holdings Corporation (Japan), Vericel Corporation (Aastrom Bioscience) (U.S.), Brainstorm cell therapeutics (U.S.), Becton, Dickinson and Company (U.S.), Stryker Corporation (U.S.), Celgene Corporation (U.S.), and Osiris Therapeutics, Inc. (U.S.) to name a few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-stem-cell-therapy-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com
Spinal Implants Market : With rising appropriation of insignificant hazard spine surgeries, spinal inserts advertise foreseen to develop at critical rate over the conjecture time frame. Spinal inserts have favorable position over the open spine surgeries like generally safe of contamination, torment, muscle harm, negligible blood misfortune and quicker recuperation time, every one of these variables are prompting expanding number of patients embracing spinal embeds and driving business sector development for spinal embed. What's more, ascent in geriatric populace and innovative improvements in bone uniting items are anticipated to drive the development of spinal embed showcase over conjecture period. Be that as it may, stringent controls, absence of sufficient mindfulness about the new methodology among human services proficient and patients, and the high cost of systems are thwarting the spinal inserts advertise development.
A sample of this report is available upon request @
Spinal implants market has been segmented based on product type, surgery type, procedure type, and end-user
By product type, spinal implants market is segmented into
By surgery, spinal implants market is segmented into
Based on end-user, spinal implants market is segmented into
To view TOC of this report is available upon request @
Global spinal implants market is exhibiting steady growth with significant CAGR over the forecast period. Traditional spine surgery segment is dominated and accounted for the more share in spinal implants market. Rise in the preference for non-fusion procedures over the fusion procedures is one of the trends in spinal implants market. Government initiatives and technological developments in treatment and development of advanced spinal implants driving the spinal implants market revenue growth. For instance, the American Academy of Orthopedic Surgeons and North American Spine Foundation, both contribute towards the growth of spinal implants devices market through R&D funding and training programs for healthcare professionals globally.
Need more information about this report @
Geographically spinal implants market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America is dominating the spinal implants market followed by Europe. Europe spine implants market is estimated to be dominated by new product launches and mergers & acquisitions. In 2014, Zimmer Hold Inc. launched virage OCT spinal fixation system. Moreover, increase in geriatric population and number of accidents boosting market revenue growth of spinal impants market in Europe region. According to census statistics number of people having age above 65 in Germany, Italy, UK, France and Spain together were 61, 806, 92. Asia Pacific is expected to be fastest growing market due to expansion row in health coverage, the rapid increase in healthcare infrastructure and increased funding of government on health care.
Some of the players in spinal implants market are Zimmer Biomet (U.S.), Johnson & Johnson Services Inc (U.S.), Stryker Corporation (U.S.), Benvenue Medical, Inc. (U.S.), Becton, Dickinson and Company (CareFusion Corporation) (U.S.), Alphatec Holdings, Inc. (Alohatec Spine, Inc.) (U.S.), Medtronic Plc (U.S.), Orthofix Holdings, Inc. (U.S.), and Globus Medical Inc. (U.S.) to name some few.
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-spinal-implants-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com